THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (20K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 1 sale
Filed: 5/25/2022ACC: 0001493152-22-015044
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-20K
Net shares
Net seller
$0.00
Total acquired
1
Open market trades
0B · 1S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
5/23/2022
202.84M→202.82M
Total
Net shares
−20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2022 | S · Sale | −20K | — | — | 0.0% | 202.84M | 202.82M |
| Total | −20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported